Rholence Pharmaceuticals Private Limited
About Rholence Pharmaceuticals Private Limited
Data last updated:
Rholence Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 February 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2010PTC200028. Its GSTIN is 27AAECR6379J1ZS (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pratima Rajendra Dhole and Rajendra Sheshrao Dhole.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 103 New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur, Maharashtra, India – 440024.
As per the financials filed for FY 2024, the company reported a revenue of ₹73.59 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹8.8 Lakh (net margin -12%) and EBITDA of -₹8.58 Lakh (EBITDA margin -11.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹8.92 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rholence Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address103 New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur, Maharashtra, India – 440024
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rholence Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rholence Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rholence Pharmaceuticals Private Limited, buy the company report.
Financials of Rholence Pharmaceuticals Private Limited
FY 2025 filings availableRholence Pharmaceuticals Private Limited reported revenue of ₹73.59 Lakh (up 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 16% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.7% | ||||
| Net Profit Margin | -12% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rholence Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rholence Pharmaceuticals Private Limited
Rholence Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratima Rajendra Dhole | Director | 12 Feb 2010 | 16 Years 8 Months | Current |
| Rajendra Sheshrao Dhole | Director | 12 Feb 2010 | 16 Years 8 Months | Current |
Shareholding
The shareholding of Rholence Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rholence Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jun 2020 | 100358637 | Others | ₹92,000 | Open | |
| 28 Feb 2019 | 100248337 | Others | ₹8 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Rholence Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rholence Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rholence Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECR6379J1ZS | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rholence Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rholence Pharmaceuticals Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Kiran Ravindra Dhole ceased to be Director on 07 Dec 2018.
Frequently asked questions
Rholence Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 February 2010 (16+ years old) and is registered under CIN U24100MH2010PTC200028.
Rholence Pharmaceuticals has 2 current directors:
- Pratima Rajendra Dhole - Director
- Rajendra Sheshrao Dhole - Director
The latest financial statements of Rholence Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rholence Pharmaceuticals is 27AAECR6379J1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rholence Pharmaceuticals is U24100MH2010PTC200028. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rholence Pharmaceuticals was incorporated on 12 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Kiran Ravindra Dhole ceased to be Director on 07 Dec 2018. Ravindra Sheshrao Dhole ceased to be Director on 07 Dec 2018. Pratima Rajendra Dhole was appointed as Director on 12 Feb 2010. Rholence Pharmaceuticals has 4 board changes on record in total.
The registered office of Rholence Pharmaceuticals is at 103 New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur, Maharashtra, India – 440024.
Rholence Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Rholence Pharmaceuticals has open charges of ₹8.92 Lakh and no satisfied charges on record as per latest MCA filings.